# Testing the Value of Novel Strategy and Its Cost Efficacy in Order to Improve the Poor Outcomes in Cardiogenic Shock

> **NCT03813134** · NA · UNKNOWN · sponsor: **University of Leicester** · enrollment: 428 (estimated)

## Conditions studied

- Cardiogenic Shock

## Interventions

- **PROCEDURE:** Percutaneous coronary intervention (PCI)
- **OTHER:** Pharmacological Support
- **DEVICE:** VA-ECMO

## Key facts

- **NCT ID:** NCT03813134
- **Lead sponsor:** University of Leicester
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-11
- **Primary completion:** 2023-03-03
- **Final completion:** 2024-02-01
- **Target enrollment:** 428 (ESTIMATED)
- **Last updated:** 2021-05-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03813134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03813134, "Testing the Value of Novel Strategy and Its Cost Efficacy in Order to Improve the Poor Outcomes in Cardiogenic Shock". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03813134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*